SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-164641
Filing Date
2017-01-03
Accepted
2016-12-30 20:19:51
Documents
7
Period of Report
2016-12-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-23919_18k.htm 8-K 90908
2 EX-3.1 a16-23919_1ex3d1.htm EX-3.1 34689
3 EX-3.2 a16-23919_1ex3d2.htm EX-3.2 10368
4 EX-10.1 a16-23919_1ex10d1.htm EX-10.1 110984
5 EX-10.6 a16-23919_1ex10d6.htm EX-10.6 85952
6 EX-99.1 a16-23919_1ex99d1.htm EX-99.1 7532
7 GRAPHIC g239191la01i001.jpg GRAPHIC 3161
  Complete submission text file 0001104659-16-164641.txt   346929
Mailing Address 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746
Business Address 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 AUSTIN TX 78746 512-279-5100
Apollo Endosurgery, Inc. (Filer) CIK: 0001251769 (see all company filings)

IRS No.: 161630142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35706 | Film No.: 162078335
SIC: 2836 Biological Products, (No Diagnostic Substances)